Del Gaizo Moore, V., Brown, J. R., Certo, M., Love, T. M., Novina, C. D., & Letai, A. (2007). Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737. American Society for Clinical Investigation.
Chicago Stili AlıntıDel Gaizo Moore, Victoria, Jennifer R. Brown, Michael Certo, Tara M. Love, Carl D. Novina, ve Anthony Letai. Chronic Lymphocytic Leukemia Requires BCL2 to Sequester Prodeath BIM, Explaining Sensitivity to BCL2 Antagonist ABT-737. American Society for Clinical Investigation, 2007.
MLA AlıntıDel Gaizo Moore, Victoria, et al. Chronic Lymphocytic Leukemia Requires BCL2 to Sequester Prodeath BIM, Explaining Sensitivity to BCL2 Antagonist ABT-737. American Society for Clinical Investigation, 2007.